Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer

This randomized controlled Phase III trial was designed to evaluate the effect of vitamin D supplementation (VD) on chemotherapy side effects following adjuvant chemotherapy in breast cancer

Trial Details

NCT ID
NCT06642441
Phase
NA
Sponsor
Jiuda Zhao
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Chemotherapy + vitamin D2
  • Chemotherapy
Locations (sample)
  • Xining, Qinghai, China|36.62554,101.75739
  • Xining, Qinghai, China|36.62554,101.75739

Key Eligibility Criteria

  • Age between 18 and 80 years, with an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.
  • Primary diagnosis of breast cancer confirmed by preoperative pathological examination.
  • Serum 25(OH)D levels less than 20 ng/ml (50 nmol/L).
  • Patients who have not previously received chemotherapy and who plan to undergo at least 4 cycles of

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →